Skip to main content
. Author manuscript; available in PMC: 2022 Jun 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2020 Oct 1;19(6):1267–1274.e1. doi: 10.1016/j.cgh.2020.09.045

Table 3.

Association of Free Testosterone with NASH and NASH Fibrosis in Youngest Age Quartile After Excluding Polycystic Ovary Syndrome (n=39)

NAFLD Comparisons Unadjusted OR
(95% CI), p value		 Adjusted OR*
(95% CI), p value
NASH (vs NAFL) 2.80 (1.35-5.79),
p=0.006		 2.29 (1.06-4.93),
p=0.035
Any fibrosis 2.27 (1.16-4.43),
p=0.016		 1.97 (1.03-3.79),
p=0.041
Higher fibrosis stage 2.28 (1.23-4.22),
p=0.009		 1.93 (0.95-3.90),
p=0.069

PCOS defined as self-report or having elevated free testosterone and irregular menses.

**

Adjusted for DM2 and abdominal adiposity (waist >88cm). Dyslipidemia fell out of model as all women with the limited number of fibrosis (n=22) and NASH (n=23) events also had dyslipidemia.